Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT02255617 - Fecal Microbiota Transplantation (FMT) & Hepatic encephalopathy (HE)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Study overview:

NCT02255617 - Fecal Microbiota Transplantation (FMT) & Hepatic encephalopathy (HE) is a clinical phase I/II treatment trial studying Fecal Microbiota Transplantation (FMT) in cirrhotic patients with Hepatic encephalopathy (HE)

Primary outcome measures:

Portion of participants with normalization of Inhibitory Control Test (ICT) (i.e., a computerized neuropsychological test) or Stroop Test during the study

Results:

No published results are currently available as of January 2026
…

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!